Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4.22x is 100% above its 2-year average of -1064.46x, near the high end of its 2-year range (-7340.67x–-2.07x).
99.78% above its 12-month average of -1913.86x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -7340.67x.
INTEREST COVERAGE RATIO
-4.22x
INTEREST COVERAGE RATIO AVG TTM
-1913.86x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+99.78%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 468 covered companies
CURRENT VS SECTOR MEDIAN
+25.24%
vs the sector median at left
Heartflow, Inc. Common Stock
Market Cap
$4.37B
Interest Coverage Ratio
-4.22x
TTM Avg
-1913.86x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.37B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.39B
Interest Coverage Ratio
-4.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.42B
Interest Coverage Ratio
5.89x
TTM Avg
3.33x
3Y Avg
3.33x
5Y Avg
4.95x
Market Cap
$4.56B
Interest Coverage Ratio
168.66x
TTM Avg
168.66x
3Y Avg
168.66x
5Y Avg
168.66x
Market Cap
$4.15B
Interest Coverage Ratio
4.05x
TTM Avg
3.05x
3Y Avg
3.05x
5Y Avg
3.05x
Market Cap
$4.13B
Interest Coverage Ratio
N/A
TTM Avg
46.33x
3Y Avg
38.87x
5Y Avg
38.87x
Market Cap
$4.09B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65B
Interest Coverage Ratio
5.35x
TTM Avg
5.33x
3Y Avg
5.03x
5Y Avg
4.13x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.37B | -4.22x | -1913.86x | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.37B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | -4.85x | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.42B | 5.89x | 3.33x | 3.33x | 4.95x |
| BillionToOne, Inc. (BLLN)vs › | $4.56B | 168.66x | 168.66x | 168.66x | 168.66x |
| LivaNova PLC (LIVN)vs › | $4.15B | 4.05x | 3.05x | 3.05x | 3.05x |
| AbCellera Biologics Inc. (ABCL)vs › | $4.13B | N/A | 46.33x | 38.87x | 38.87x |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.09B | N/A | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 5.35x | 5.33x | 5.03x | 4.13x |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 2.07x | 2.07x | 2.07x | 1.38x |
Interest Coverage
-4.2x
Debt/Equity
0.10
Current Ratio
5.08
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -7340.67x |
| 2025-12-31 | -2218.75x |
| 2025-09-30 | -4.38x |
| 2025-06-30 | -2.07x |
| 2025-03-31 | -3.44x |
| 2024-12-31 | -3.12x |
| 2024-09-30 | -2.82x |
| 2024-06-30 | -2.33x |
| 2024-03-31 | -2.57x |
